New York State Common Retirement Fund’s Endocyte, Inc. Common Stock ECYT Stock Holding History

New York State Common Retirement Fund’s Portfolio ECYT Stock Details ECYT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q4	–	Sell	-72,200	Closed	-$1.28M	–	3229
2018 Q3	$1.28M	Hold	72,200	–	–	﹤0.01%	1948
2018 Q2	$996K	Buy	+72,200	New	+$857K	﹤0.01%	2100
2017 Q2	–	Sell	-72,923	Closed	-$187K	–	3287
2017 Q1	$187K	Buy	72,923 +18,752	+35%	+$43.4K	﹤0.01%	2792
2016 Q4	$138K	Hold	54,171	–	–	﹤0.01%	2896
2016 Q3	$167K	Hold	54,171	–	–	﹤0.01%	2819
2016 Q2	$174K	Hold	54,171	–	–	﹤0.01%	2796
2016 Q1	$168K	Hold	54,171	–	–	﹤0.01%	2752
2015 Q4	$217K	Hold	54,171	–	–	﹤0.01%	2726
2015 Q3	$248K	Sell	54,171 -5,838	-10%	-$30.6K	﹤0.01%	2671
2015 Q2	$311K	Buy	60,009 +40,038	+200%	+$240K	﹤0.01%	2742
2015 Q1	$125K	Buy	+19,971	New	+$115K	﹤0.01%	2206
2014 Q2	–	Sell	-111,525	Closed	-$2.65M	–	2042
2014 Q1	$2.65M	Buy	+111,525	New	+$1.62M	﹤0.01%	1521

Other funds holding ECYT

OTC

Opera Trading Capital Paris, France $419M AUM 0.58% 1-Year Est. Return

Claro Advisors Boston, Massachusetts $953M AUM 24.79% 1-Year Est. Return

New York State Common Retirement Fund's ECYT Position: Q4 2018 in Review

New York State Common Retirement Fund sold out of Endocyte, Inc. Common Stock (ECYT) in Q4 2018, closing a stake of 72,200 shares — an estimated $1.28M sold.

New York State Common Retirement Fund first reported a position in ECYT in Q1 2014 and held it in 12 quarters. The position peaked at $2.65M in Q1 2014. 2 funds tracked by Wall St. Rank hold ECYT as of Q4 2018.

New York State Common Retirement Fund reported no remaining Endocyte, Inc. Common Stock position as of Q4 2018 after selling out during the quarter.
New York State Common Retirement Fund sold 72,200 Endocyte, Inc. Common Stock shares in Q4 2018, an estimated $1.28M.
New York State Common Retirement Fund first reported a position in Endocyte, Inc. Common Stock in Q1 2014 and held it in 12 quarters.
New York State Common Retirement Fund's Endocyte, Inc. Common Stock position peaked at $2.65M in Q1 2014.
2 funds tracked by Wall St. Rank held Endocyte, Inc. Common Stock as of Q4 2018.

Based on New York State Common Retirement Fund's 13F filing for Q4 2018, filed 8 Feb 2019.